Giltuss Bucalsep Spray
NDC Package 58552-135-01
Package Information
Giltuss Bucalsep (benzocaine, menthol, zinc chloride) sprays is usesfor the temporary relief of occasional minor irritations, pain, sore mouth, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums. This formulation utilizes a spray delivery system. Marketed by Gil Pharmaceutical Corp, this product is identified by NDC 58552-135 and is authorized under FDA application M022.
Identification & Billing
- RxCUI: 2170427 - benzocaine 6.5 % / menthol 0.1 % / zinc chloride 0.12 % Mucosal Spray
- RxCUI: 2170427 - benzocaine 65 MG/ML / menthol 1 MG/ML / zinc chloride 1.2 MG/ML Mucosal Spray
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 58552 - Gil Pharmaceutical Corp
- 58552-135 - Giltuss Bucalsep
- 58552-135-01 - 1 BOTTLE, SPRAY in 1 CARTON / 30 mL in 1 BOTTLE, SPRAY
- 58552-135 - Giltuss Bucalsep
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58552-135-01 identifies a specific commercial package of 1 bottle, spray in 1 carton / 30 ml in 1 bottle, spray of Giltuss Bucalsep, a human over the counter drug labeled by Gil Pharmaceutical Corp. This spray is formulated for oral; topical use and contains benzocaine; menthol; zinc chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Gil Pharmaceutical Corp on July 26, 2018. The current certification is valid through December 31, 2026.
How is this Gil Pharmaceutical Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58552013501. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.